Protagonist Therapeutics, Inc. (PTGX)
103.97
+4.76
(+4.80%)
USD |
NASDAQ |
May 06, 16:00
104.51
+0.54
(+0.52%)
After-Hours: 06:15
Protagonist Therapeutics SG&A Expense (TTM) : 33.12M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Johnson & Johnson | 24.60B |
| AbbVie, Inc. | 14.30B |
| Insmed, Inc. | 701.17M |
| Madrigal Pharmaceuticals, Inc. | 645.95M |
| PTC Therapeutics, Inc. | 347.14M |